dc.contributor.author |
Ogura A. |
|
dc.contributor.author |
Tahara T. |
|
dc.contributor.author |
Nozaki S. |
|
dc.contributor.author |
Onoe H. |
|
dc.contributor.author |
Kurbangalieva A. |
|
dc.contributor.author |
Watanabe Y. |
|
dc.contributor.author |
Tanaka K. |
|
dc.date.accessioned |
2018-09-19T20:43:36Z |
|
dc.date.available |
2018-09-19T20:43:36Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
0960-894X |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/143184 |
|
dc.description.abstract |
© 2016 Elsevier Ltd. All rights reserved.Multivalent interactions play an essential role in molecular recognition in living systems. These effects were employed to target tumor cells using albumin clusters bearing ∼10 molecules of asparagine-linked glycans (N-glycans). Noninvasive near-infrared fluorescence imaging clearly revealed A431 tumors implanted in BALB/cA-nu/nu mice after 1 h in an N-glycan structure-dependent manner, thereby demonstrating the efficient use of glycan multivalency effects for tumor targeting in vivo. |
|
dc.relation.ispartofseries |
Bioorganic and Medicinal Chemistry Letters |
|
dc.subject |
A431 tumor |
|
dc.subject |
In vivo molecular imaging |
|
dc.subject |
Multivalency effects |
|
dc.subject |
N-Glycan |
|
dc.subject |
α(2,3)-Disialoglycan |
|
dc.title |
Glycan multivalency effects toward albumin enable N-glycan-dependent tumor targeting |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
9 |
|
dc.relation.ispartofseries-volume |
26 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
2251 |
|
dc.source.id |
SCOPUS0960894X-2016-26-9-SID84962154863 |
|